Fibroblasts from two affected members of a large pedigree in which osteogenesis imperfecta (01) type IV is genetically linked to the proa2(I) gene of type I collagen synthesize two populations of proa2(I) chains. One population is normal; the second population appears to have a deletion of about 10 amino acid residues from the middle of the triple helical domain. The mutation in proa2(I) causes increased posttranslational modification in the amino-terminal half of some proal(I) chains, lowers the melting temperature of type I collagen molecules that incorporate a mutant proa2(I) chain, and prevents or delays the secretion of those molecules from fibroblasts in cell culture. On the basis of this study and linkage studies in additional families, it appears that the 01 type IV phenotype is often the result of heterozygosity for mutations in proa2(I) that alter the triple helical structure of type I collagen.
Introduction
Most forms of osteogenesis imperfecta (OI)' are due to structural abnormalities in or decreased production of type I collagen (1) (2) (3) . Studies of collagens synthesized by cultured fibroblasts from different patients with 01 type I (4-6), 01 type 11 (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) , and 01 type III (18) (19) (20) (21) (22) have demonstrated evidence of mutations in the proal(I) and proa2(I) genes of type I collagen. There is less information regarding the biochemical basis of 01 type IV, which differs clinically from the other relatively mild autosomal dominant OI phenotype, 01 type I. Individuals with 01 type IV have normal or gray rather than blue sclerae, may have mild to moderate short stature with long bone deformity, and have a far greater incidence of dentinogenesis imperfecta (23, 24) . We have recently provided evidence of abnormal triple helical structure of type I collagen in one patient with the 01 type IV phenotype (25) , and Tsipouras et al. have demonstrated linkage of the OI type IV phenotype to the proa2(I) gene of type I collagen on chromosome 7 in four pedigrees (26) (27) (28) .
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1. Abbreviations used in this paper: DMEM, Dulbecco's modified Eagle's medium; FCS, fetal calf serum; 01, osteogenesis imperfecta; PAGE, polyacrylamide gel electrophoresis.
as type I collagen, we chose to study cell strains from individuals in a large pedigree in which there is evidence of linkage of the 01 type IV phenotype to the proa2(I) gene (26) . This approach enabled us to focus attention on only one class of constituent chains of type I collagen. In this report we describe studies of type I collagen synthesized by cells cultured from one unaffected and two affected members of this pedigree (26) . The affected members are heterozygous for a mutation in the proa2(I) gene that produces a shortened proa2(I) chain, thus confirming linkage in this family. The deletion from the middle of the triple helical domain of a2(I) causes excessive posttranslational modification ofthe amino-terminal half ofthe a-chains in molecules that contain the shortened a2(I) chains. Molecules that contain the mutant a2(I) chains are selectively retained within fibroblasts. These studies provide direct evidence that mutations in a2(I) are responsible for the clinical and biochemical features of OI type IV in this family and, in the context of additional linkage data (27, 28) and biochemical studies (reference 25, Wenstrup, R. J., and P. H. Byers, unpublished observations), suggest that many individuals with OI type IV have mutations in a2(I).
Methods
Fig . I shows the pedigree. Cells from one unaffected member (II-3) and two affected family members (11-5 and 111-6) were studied. The details of physical findings for 11-5 and 111-6 are presented here and individuals heterozygous (-/+) and homozygous for the absence (-/-) and presence (+/+) of a polymorphic EcoRI site in a2(I); horizontal bars, individuals examined by one of us (Dr. P. Tsipouras); solid circles, solid squares, affected by OI; arrows, studied biochemically in this paper.
To label proteins for analysis of procollagens or collagens, 2.5 X 101 cells were plated in 35-mm culture dishes (Coming Science Products, Coming, NY) and allowed to attach and spread overnight. Unless otherwise indicated, the cells were preincubated for 4 h in 0.7 ml DMEM lacking FCS and supplemented with 50 lg/ml ascorbic acid. The proteins were radiolabeled by addition of [2,3,4,5-3H]-proline (108 Ci/mmol; Amersham Corp., Arlington Heights, IL) at concentrations of 30 to 120 MCi/ml, depending on the studies planned. After 16 h incubation, medium and cell layer proteins were harvested separately and proteolytic enzymes were inhibited as described (7) . Samples were concentrated by precipitation with 30% ethanol followed by air drying. Medium and cell layer procollagens were analyzed under reducing conditions on 5% sodium dodecyl sulfate (SDS) polyacrylamide gels as described by Laemmli (29) except that 2 M urea was included in the system to enhance the separation of proal(I) from proal(III) chains. Dried procollagens were dissolved in 60 Ml of sample buffer with 7.7 mg/ml dithiothreitol and boiled for 3 min to reduce disulfide bonds and denature the procollagen molecules. After electrophoresis, radioactive proteins were detected by radio-autofluorography (30) using EN3HANCE (New England Nuclear, Boston, MA) as the fluor.
To examine ratios of newly synthesized proa(I) to proa2(I) chains, The ratio of type I to type III secreted collagen into culture medium during a 16-h incubation was measured by gel densitometry of fluorograms exposed in the linear range (31) . The density of all the proa, pCa, pNa, and a chains was determined and summed for each collagen. Incorporation of [3Hjproline into collagenous protein was measured by bacterial collagenase digestion as previously described (32) .
To examine unmodified proa chains, 2.5 X l0s cells were plated as above and then were preincubated for 4 h in 0.7 ml DMEM that lacked FCS but contained 50 ,Ag/ml ofascorbic acid and 0.5 mM a,a-dipyridyl.
The cells were then incubated with 100 ACi/ml of [3H]proline for 16 h under identical conditions. Cell layer proteins were harvested and analyzed by electrophoresis under reducing conditions as described above.
Collagens were prepared by dissolving ethanol-precipitated procollagens in 0.5 N acetic acid and digesting with 50 jsg/ml pepsin (Boehringer Mannheim Diagnostics, Houston, TX) at 4°C for 16 h. The reaction was terminated by adding pepstatin to S ,g/ml and molecules were concentrated by lyophilization and analyzed by electrophoresis. CNBr cleavage of a-chains and of fibroblast collagenase products of a-chains oftype I collagen in gels was performed as previously described (34) except that digestion was limited to 2 h and the samples were subsequently washed three times with 20 vol of water for 10 min each (13) .
The peptides were separated on second-dimension gels as described (34) .
In some experiments, collagenous proteins were cleaved sequentially by pepsin, fibroblast collagenase, and CNBr. The collagenase fragments were cleaved with 20 ,g/ml CNBr in 70% formic acid at 30°C for 5 h, lyophilized, washed in distilled H20, and lyophilized again. The peptides were separated by isoelectric focusing in a vertical slab gel using the gel composition and buffers previously described (35) . After first-dimension electrophoresis, gel strips were cut out and washed in 30 vol ofwater for 20 min three times, then twice in 15 vol of 30% glycerol, 0. 1 M Tris-HC1 (pH 6.8) for 10 min, and loaded onto a 12.5% SDS polyacrylamide gel with a 5% stacking gel for separation of peptides in the second dimension.
Thermal denaturation temperatures of normal and abnormal collagens were determined as previously described (36) .
Results
Dermal fibroblasts from two affected members of this family synthesized two populations of proal(I) chains of type I procollagen. One population co-migrated with the corresponding proal(I) chains synthesized by cells from the control and from (Fig. 3) . a-Chains were separated in the VI_. 111-6 C 11-5 11-3 111-6 C 11-5 11-3 Medium Cells Figure 2 . Autoradiofluorograms of radiolabeled procollagens after SDS PAGE (A) Proa chains from medium and cell layer. There was a slower migrating population of proa I(I) chains (arrows) from the cell layer of 01 cell strains (11-5 and III-6) not seen in control (C) or the unaffected family member Fig. 3 B) , the slower migrating a I (I)A fragment produced a peptide that migrated more slowly than al(I)CB3, a normally migrating al(I)CB7A, and a peptide that migrated more slowly than al(I)CB8. Thus, the slower migrating population of al(I) was overmodified amino-terminal to the a l(I)CB7 domain. These findings contained an apparent paradox: although the genetic linkage data (26) indicated that the mutation should be in an a2(I) chain, the evident structural abnormality in type I collagen was overmodification of the amino-terminal half of some intracellular al(I) chains produced by the OI cells. Because Steinmann et al. (12) have demonstrated that a mutation of a 1(I) could cause overmodification in all three constituent achains in a molecule at residues amino-terminal to the mutation, we hypothesized that a mutation in the middle ofan a2(I) chain might also cause excessive posttranslational modification aminoterminal to its location in all chains in such a molecule but that because a2(I) normally is more modified than a 1(I), overmodification in a2(I) might be more difficult to detect. Because overmodification of abnormal molecules involved only the aminoterminal halfofthe triple helical domain, we examined the region in the middle ofthe triple helical domain ofa2(I) in more detail. Because the methionyl residue between a2(I)CB3 and a2(I)CB5 is inefficiently cleaved by CNBr, a-chains were cleaved with fibroblast collagenase and then cleaved with CNBr (see diagram, Fig. 3 C, for relative locations of CNBr and fibroblast cleavage sites). Peptides cleaved in this way were separated first by isoelectric focusing in a 5% polyacrylamide gel, then gel strips were placed over a 12.5% SDS polyacrylamide gel and peptides were separated by molecular weight in a second dimension (Fig. 4) . Although each peptide was heterogeneous with respect to charge as has been reported elsewhere (35, 37) , the cell layer samples of the 01 cell strains (Fig. 4 B , and lower right, C) contained two major populations of a2(I)CB3-5A. One population was in normal position, and a second population migrated further (vertically) into the second-dimension gel and had a more acidic isoelectric point (shifted leftward in the figure) . This second population of a2(I)CB3-5A was not present in collagens secreted by 01 cells or in the cell layer or secreted collagens of control cells or those from the unaffected family member. These findings are consistent with a small deletion, of about 10 residues, in the a2(I)CB3-5A peptide that involves the net loss of at least one basic residue. Because we did not observe the shortened a2(I) fragment in the medium, we determined whether the shortened a2(I) chain affected the thermal stability of type I collagen mol- Figure 4 . Autoradiofluorograms of two-dimensional maps of peptides generated by cleavage with fibroblast collagenase and CNBr from collagens from control (C) and 01 (III-6) cells. Peptides were separated first by isoelectric focusing in a 5% polyacrylamide gel, then separated by molecular weight in a 12.5% SDS polyacrylamide gel in the second dimension. The methionine between a2(I)CB3 and a2(I)CB5 is inefficiently cleaved by CNBr. All peptides usually show charge heterogeneity. In B, which shows peptides generated from intracellular collagens from 111-6, there was a second, abnormal population of al(I)CB3-5A which appeared shortened and was more acidic than normal (arrows).
Other peptides from 111-6 were normal except for evidence of overmodification of some al(I)CB8 and al(I)CB3 peptides. The abnormal population of a2(I)CB3-5A was not seen in fibroblast medium from 111-6 (inset at top right, B), in the cell layer or medium from control (A and inset in A), or unaffected family member (11-3, C), or in medium from the other affected family member (II-5, C). Autoradiofluorogram showing melting temperatures of intracellular type I collagen molecules from control (C) and OI (III-6) fibroblasts. Pepsin-digested samples were gradually warmed from 300 to 43°C at the rate of 1°C/12 min, and samples were removed at L.0°C intervals, rapidly cooled to 20'C, and then digested with trypsin for 2 min. After trypsin digestion, samples were separated on a 5% SDS polyacrylamide gel. Molecules containing overmodified al(I) chains from OI cells were digested at -35°C (slanted arrow) as compared with normally migrating type I collagen molecules (vertical arrows) and type I collagen molecules from control cells, which became protease sensitive at 42°C. ecules that contained them (Fig. 5) . Type I collagen from each 01 cell strain had a biphasic curve: molecules that contained overmodified a I(I) chains (presumably a marker for molecules containing a mutant a2[I] chain) melted at 35°C, as compared with molecules that contained normally migrating al (I) and a2(I) chains from 01 and control cells, which melted at 42°C.
To determine whether the decreased triple helical stability of some type I procollagen molecules resulted in reduced secretion into fibroblast medium, we measured the ratios of type I to type III collagen chains in fibroblast medium after a 16-h incubation with [3H1proline. Type I collagen/type III collagen ratios were 3.14 (II-5) and 3.85 (11-6) for 01 cell strains compared with 3.58 for control. Quantitation of collagen production by bacterial collagenase assay (29) (Table II) demonstrated that for 01 cells, 22% (II-5) and 33% (III-6) of incorporated [3H]proline was in collagenous protein compared with 25% for control. Finally, to determine whether the mutation in proa2(I) altered the rate of production of proa2(I) chains, ratios of newly synthesized proal(I) to proa2(I) chains were determined. The ratio of proal(I) to proa2(I) was 2.12 for one 01 cell strain (11-5) and was 2.02 for control.
Discussion
Cultured dermal fibroblasts from two affected members of a large family in which 01 type IV is linked to the proa2(I) gene synthesize two populations of proa2(I) chains. One population is normal and is present in both medium and cell layer samples. A second population, found only within the cells, is shortened by about 10 amino acid residues and the CNBr peptide fragment containing the apparent deletion has a more acidic isoelectric point than the normal peptide. The effect of the mutation is to cause increased posttranslational modification ofthe amino-terminal half of some intracellular al(I) chains, presumably those a 1 (I) chains that are incorporated into molecules that also contain the shortened a2(I) chain. The (12, 17) . However, evidence from another lethal OI cell strain suggests that a deletion within the triple helical domain may produce similar effects even if the (Gly-X-Y). sequence is preserved. That cell strain was heterozygous for an intron-to-intron deletion of three exons, with preservation of (Gly-X-Y)n in the shortened chain. The melting temperature of molecules that contained the abnormal allelic product was lower than normal and in those molecules there was overmodification of the amino-terminal region of a 1(I) (7, 8, 10, 11; Bonadio, J. F., and P. H. Byers, unpublished observations). Failure to detect overmodified proa2(I) chains in the cell strains described in the present report may reflect the fact that proa2(I) is normally modified to a greater extent than proal(I) (16) , so that there may be few additional sites in the aminoterminal half of a2(I) chains available for further modification. Further, failure to detect the shortened unmodified proa2(I) probably reflects limitations ofresolution (Fig. 2 B) . This OI cell strain provides additional support for the concept that overmodification of chains of type I collagen is common in cells from patients with certain forms of OI, that the extent of overmodification helps to locate a domain that contains a mutation, and that the abnormal structure contributes to the pathophysiology of the disease (1, 12, 13, 15, 25) .
01 type IV is a mild to moderately severe phenotype characterized by white or grey sclerae, bone fragility, moderate short stature with frequent deformity, a high incidence of dentinogenesis imperfecta, and autosomal dominant inheritance. Based on the biochemical findings in this report, which confirm genetic linkage of 01 type IV to the proa2(I) locus in this family, and on linkage studies on other 01 type IV families (27, 28) , it now appears that the clinical distinction between 01 type I and 01 type IV is the result of different mutations in the genes of type I collagen, which in turn have differing effects on the amount and quality of bone matrix. In classic OI type I, there is simply a decrease in the amount of type I collagen produced by dermal fibroblasts (1, 4, 6) (though the molecular causes will undoubtedly prove to be heterogeneous), but in most cases of 01 type IV there is a subpopulation of type I collagen molecules with altered triple helical structure and increased posttranslational modification (41), probably due to subtle mutations in proa2(I). It is unclear whether ineffective bone mineralization is the result of overmodification, as has been suggested (42, 43) , or whether it is due to the mutation itself. We are uncertain whether molecules that contain the mutant a2(I) chains from the present family are secreted by osteoblasts or are incorporated into bony matrix. An 
